Enables high-throughput construct design (up to 1,000 constructs) with real-time data sharingIntegrated, AI-ready biologics ecosystem: Connects design to execution through native Signals One platform ...
Jacob Funds, a mutual fund company, released its first-quarter 2026 investor letter. A copy of the letter can be downloaded ...
Novonesis and the Technical University of Denmark's Bright hub are turning CO2 into protein, as part of a consortium backed ...
ClearBridge Investments, a global equity manager, recently published first-quarter 2026 commentary for its “Small Cap Growth Strategy”. A copy of the letter can be downloaded here. The beginning of ...
Jawaharlal Nehru University will soon open postgraduate admissions for 2026-27 following the CUET-PG results. Applicants are advised to review the prospectus and prepare necessary documents. Various ...
"We are executing with urgency and purpose as we advance our pipeline assets to the clinic as expeditiously as possible," said Rick Pierce, Chief Executive Officer of Decoy Therapeutics. "We are ...
JNU releases prospectus 2026-27, will start PG admissions after CUET-PG results are declared. Candidates must check ...
A review highlighted the potential of CAR therapies to treat neurodegenerative disorders. Key challenges include targeting diverse protein aggregates and avoiding toxicity. However, the review ...
Sibel Health today announced FDA 510(k) clearance of ANNE® Maternal, the world's first fully wireless, comprehensive maternal-fetal monitoring platform. Designed for continuous, simultaneous ...
The application of CAR immunotherapies to neurodegenerative diseases is limited by major challenges due to the complex nature ...
A UAB research team defines the criteria that CAR immunotherapies for neurodegenerative diseases must meet to advance both ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results